Medical technologies group Norwood Abbey Ltd [ASX:NAL] advises that the commercialisation phase of the needle-free injection system project is progressing. During the past six months, the company has received unsolicited approaches, in relation to the technology, from a number of sources. Preliminary discussions have been undertaken with a number of parties. The parties include prominent pharmaceutical groups, one medical consulting group and a number of research hospitals, all of whom have expressed interest in the human applications of the technology. Two groups have approached the company regarding veterinary applications of the technology..........
No idea if its the reason for s.p.increase , but its a possibility..
NAL Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held